| Name | Title | Contact Details |
|---|
Avaxia is a leader in the growing field of gut-targeted therapeutics — orally administered, minimally absorbed drugs that are designed to act locally in the gastrointestinal tract. Avaxia’s lead clinical candidate, AVX-470, is an oral anti-TNF antibody for inflammatory bowel disease. This transformative product offers potentially improved safety and efficacy over existing anti-TNF therapies by focusing immune suppression only where needed in the diseased gut. Avaxia plans to use its gut-targeted antibody platform to develop therapeutics to address many other serious diseases such as type 2 diabetes, celiac disease, GI acute radiation syndrome and oral mucositis.
Michigan Academy of Family Physicians is a Okemos, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
lifeIMAGE is an interoperable medical image sharing network that helps healthcare providers access their patients` imaging records, regardless of where exams are performed or stored. It has been adopted by more than 120 multi-site health systems across the country to improve care coordination for patient consultations, referrals and transfers. This enables providers to improve the quality and timeliness of care, expand referral business, and eliminate wasteful spending.
Zynx Health, a subsidiary of Hearst Corporation, is the market leader in providing evidence-based and experience-based clinical decision support solutions proven to measurably improve the quality, safety, and efficiency of patient care.
Redco Group is a Stroudsburg, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.